Evercore ISI upgraded Labcorp (LH) to Outperform from In Line with a price target of $265, up from $260. The firm sees upside to consensus EPS estimates for 2025 and later, largely driven by “still-solid” base testing growth, as well as Invitae and diagnostic margin expansion, the analyst tells investors. 2025 lab volume growth should remain solid, even if utilization trends soften somewhat, the analyst added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH: